Company: REVB
Filing Date: 2025-05-20
Form Type: CORRESP
Source: 0001213900-25-046001
Chunk: 0

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: CORRESP
Chunk 0
---
<div align='center'>REVELATION BIOSCIENCES, INC.

4660 La Jolla Village Drive, Suite 100

San Diego, CA 92122</div>

May 20, 2025

VIA EDGAR AND E-MAIL

Mr. Allan Campbell

Office of Life Sciences

Division of Corporate Finance

U.S. Securities and Exchange Commission

100 F. Street, N.E.

Washington, DC 20549-7010

| Re: | Revelation Biosciences Inc. Registration Statement on 
 Form S-1;                                             |
|     | Commission File No. 333-287423                        |

Dear Mr.Campbell:

Pursuant to Rule 461 promulgated under the Securities Act of 1933,
as amended, Revelation Biosciences Inc. (the “Company”) hereby requests that the effectiveness of the Company’s Registration
Statement on Form S-1 (File No. 333-287423) be accelerated by the U.S. Securities and Exchange Commission to 5:00 p.m. Eastern Time
on Thursday, May 22, 2025, or as soon thereafter is practicable.

The Company hereby authorizes Joseph P. Galda of J.P. Galda & Co.
to orally modify or withdraw this request for acceleration. Please contact Mr. Galda at (215) 815-1534 with any questions you may have
concerning this request, and please notify him when this request for acceleration has been granted.

Thank you for your courtesy and cooperation in this matter.

Very truly yours,

REVELATION BIOSCIENCES, INC.

| By: | /s/ Chester S. Zygmont, III  |
|     | Chester S. Zygmont, III, CFO |